Inhibrx, Inc. (INBX)

Inhibrx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022
Receivables	0.78	0.26
Other Current Assets	12.69	6.01
Total Current Assets	13.47	6.26
Property, Plant & Equipment	9.37	7.22
Other Long-Term Assets	3.16	3.16
Total Long-Term Assets	12.54	10.38
Total Assets	26	16.65
Accounts Payable	8.31	4.34
Current Debt	2.06	1.86
Other Current Liabilities	22.49	14.57
Total Current Liabilities	32.86	20.77
Long-Term Debt	1.11	3.17
Total Long-Term Liabilities	1.11	3.17
Total Liabilities	33.97	23.95
Total Debt	3.17	5.03
Debt Growth	-36.96%	-
Shareholders' Equity	-7.97	-7.3
Net Cash / Debt	-3.17	-5.03
Working Capital	-19.4	-14.51
Book Value Per Share	-0.60	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).